Open AccessAntifungal activity of curcumin-silver nanoparticles against fluconazole-resistant clinical isolates of Candida species
Author(s) -
Sony Paul,
Kalyani Mohanram,
Iyanar Kannan
Publication year - 2018
Publication title -
ayu
Language(s) - English
Resource type - Journals
eISSN - 0976-9382
pISSN - 0974-8520
DOI - 10.4103/ayu.ayu_24_18
Subject(s) - fluconazole , curcumin , candida glabrata , candida albicans , candida tropicalis , microbiology and biotechnology , agar diffusion test , corpus albicans , chemistry , agar , silver nanoparticle , minimum inhibitory concentration , antifungal , agar dilution , antimicrobial , biology , nanoparticle , bacteria , escherichia coli , biochemistry , materials science , nanotechnology , genetics , gene
Candida species is the common form of opportunistic fungal infections, especially in immunosuppressed individuals. Fluconazole is the first-line therapy for candidiasis as it is affordable and readily available. However, the antifungal resistance pattern in high-risk patients is a major concern.